kidney neoplasms

Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Shohei Fukuda, Kazutaka Saito, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Yukio Kageyama, Yasuhisa Fujii

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001564; DOI: 10.1136/jitc-2020-001564
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Benjamin Switzer, John Haanen, Paul C Lorigan, Igor Puzanov, Samra Turajlic

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002835; DOI: 10.1136/jitc-2021-002835
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, Tharakeswara K Bathala, Devaki Shilpa Surasi, Jianjun Gao, Amishi Shah, Matthew T Campbell, Pavlos Msaouel, Sangeeta Goswami, Jennifer Wang, Amado J Zurita, Eric Jonasch, Paul G Corn, Ana M Aparicio, Arlene O Siefker-Radtke, Padmanee Sharma, Sumit K Subudhi, Nizar Tannir

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002850; DOI: 10.1136/jitc-2021-002850
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
Niklas Klümper, Damian J Ralser, Romina Zarbl, Katrin Schlack, Andres Jan Schrader, Marc Rehlinghaus, Michèle J Hoffmann, Günter Niegisch, Annemarie Uhlig, Lutz Trojan, Julie Steinestel, Konrad Steinestel, Ralph M Wirtz, Danijel Sikic, Markus Eckstein, Glen Kristiansen, Marieta Toma, Michael Hölzel, Manuel Ritter, Sebastian Strieth, Jörg Ellinger, Dimo Dietrich

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e002949; DOI: 10.1136/jitc-2021-002949
In silico modeling of combination systemic therapy for advanced renal cell carcinoma
Ritesh R Kotecha, Dennis J Hsu, Chung-Han Lee, Sujata Patil, Martin H Voss

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e004059; DOI: 10.1136/jitc-2021-004059
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
Nizar M Tannir, Daniel C Cho, Adi Diab, Mario Sznol, Mehmet A Bilen, Arjun V Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Jonathan Zalevsky, Arlene O Siefker-Radtke, Michael E Hurwitz

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004419; DOI: 10.1136/jitc-2021-004419
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC
Petra Ross-Macdonald, Alice M Walsh, Scott D Chasalow, Ron Ammar, Simon Papillon-Cavanagh, Peter M Szabo, Toni K Choueiri, Mario Sznol, Megan Wind-Rotolo

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e001506; DOI: 10.1136/jitc-2020-001506
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, Hannah Dzimitrowicz, Abhishek Tripathi, Benoit Beuselinck, Elaine Lam, Yousef Zakharia, Rana Mckay, Sumit Shah, Amir Mortazavi, Michael R. Harrison, Spyridon Sideris, Marina D Kaymakcalan, Sarah Abou Alaiwi, Amin H Nassar, Pier Vitale Nuzzo, Anis Hamid, Toni K Choueiri, Lauren C Harshman

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000538; DOI: 10.1136/jitc-2020-000538
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
Niklas Klümper, Damian J Ralser, Emma Grace Bawden, Jenny Landsberg, Romina Zarbl, Glen Kristiansen, Marieta Toma, Manuel Ritter, Michael Hölzel, Jörg Ellinger, Dimo Dietrich

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000552; DOI: 10.1136/jitc-2020-000552
Obesity diminishes response to PD-1-based immunotherapies in renal cancer
Shannon K Boi, Rachael M Orlandella, Justin Tyler Gibson, William James Turbitt, Gal Wald, Lewis Thomas, Claire Buchta Rosean, Katlyn E Norris, Megan Bing, Laura Bertrand, Brett P Gross, Amani Makkouk, Dmytro Starenki, Kristine I Farag, Robert E Sorge, James A Brown, Jennifer Gordetsky, Hesham Yasin, Rohan Garje, Lakshminarayanan Nandagopal, George J Weiner, David M Lubaroff, Rebecca C Arend, Peng Li, Yousef Zakharia, Eddy Yang, Aliasger K Salem, Kenneth Nepple, Tatiana T Marquez-Lago, Lyse A Norian

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e000725; DOI: 10.1136/jitc-2020-000725

Main menu

kidney neoplasms

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

kidney neoplasms

Pages